Drugs Containing Excipient (Inactive Ingredient) POTASSIUM CITRATE

Branded drugs containing POTASSIUM CITRATE excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Mylan Pharmaceuticals Inc	EXTINA	ketoconazole	0378-8136	POTASSIUM CITRATE
Mylan Pharmaceuticals Inc	OLUX-E	clobetasol propionate	0378-8147	POTASSIUM CITRATE
Mylan Pharmaceuticals Inc	OLUX	clobetasol propionate	0378-8182	POTASSIUM CITRATE
Mylan Pharmaceuticals Inc	LUXIQ	betamethasone valerate	0378-8187	POTASSIUM CITRATE
Almirall LLC	VERDESO	desonide	16110-111	POTASSIUM CITRATE

Generic drugs containing POTASSIUM CITRATE excipient

Company	Ingredient	NDC	Excipient
Mylan Pharmaceuticals Inc	ketoconazole	0378-8136	POTASSIUM CITRATE
Mylan Pharmaceuticals Inc	clobetasol propionate	0378-8147	POTASSIUM CITRATE
Mylan Pharmaceuticals Inc	clobetasol propionate	0378-8182	POTASSIUM CITRATE
Mylan Pharmaceuticals Inc	betamethasone valerate	0378-8187	POTASSIUM CITRATE
Almirall LLC	desonide	16110-111	POTASSIUM CITRATE

Market Dynamics and Financial Trajectory for Potassium Citrate

Last updated: February 20, 2026

Potassium citrate, a widely used pharmaceutical excipient and active pharmaceutical ingredient (API), presents a growing market driven by increasing demand in pharmaceuticals, food, and industrial applications. The compound’s diverse roles, including buffering capacity, anticoagulant properties, and as a dietary supplement, influence its market growth trajectory.

Market Overview

The potassium citrate market was valued at approximately USD 250 million in 2022. It is projected to reach USD 350 million by 2030, with a compound annual growth rate (CAGR) of 4.5% from 2023 to 2030. This growth hinges on rising prevalence of kidney stones, expanding pharmaceutical manufacturing, and application in food and beverage sectors.

Key Market Drivers

increasing prevalence of kidney stones

Potassium citrate is prescribed to prevent and treat kidney stone formation by alkalizing urine. The rise in nephrolithiasis, affecting nearly 10% of the global population, expands its usage in pharmaceuticals.

growing pharmaceutical formulations

Potassium citrate’s buffering capacity makes it vital in formulations for metabolic acidosis, urinary alkalization, and electrolyte balance, increasing manufacturing volumes.

expanding food and beverage applications

Used as a food additive (E332) and acidity regulator, its demand increases with the growth of processed foods, especially in regions like Asia-Pacific.

regulatory and industry policies

The approval of potassium citrate as an approved food additive and pharmaceutical ingredient in major markets reinforces stable demand.

Market Challenges

raw material price volatility

The raw materials (potassium salts) experience price fluctuations influenced by energy prices and geopolitical factors, impacting profit margins.

regulatory hurdles

Stringent regulations and approval processes across countries can delay market expansion, especially in emerging markets.

environmental considerations

Environmental concerns surrounding potassium salt mining and processing pose sustainability challenges, with potential impact on costs and supply chain stability.

Key Market Segments

Segment	2022 Market Share	Growth Drivers
Pharmaceutical	60%	Kidney stone treatment, metabolic disorders, electrolytes
Food & Beverage	25%	Acid regulation, preservative
Industrial & Other	15%	Water treatment, personal care products

Competitive Landscape

Major producers include Merck KGaA, J.T. Baker, and Spectrum Chemical. The market also sees regional players in Asia-Pacific leading in raw material production, with notable R&D focus on formulation improvements and sustainable sourcing.

Financial Trajectory

Revenue growth

The market’s revenue is expected to increase at a CAGR of approximately 4.5%. Key revenue sources are pharmaceutical manufacturing (60%) and food additive applications (25%). Price points range from USD 8 to USD 15 per kilogram, depending on purity and grade.

Investment patterns

Investments in manufacturing capacity expansion and R&D are consistent, aligned with rising demand and regulatory approvals. Capital expenditure is highest in China and India, where large-scale production facilities are being established.

Profitability outlook

Gross margins range from 25% to 35%, influenced by raw material costs and process efficiencies. R&D costs constitute about 3–5% of revenues, primarily directed toward formulation innovation and quality enhancements.

Future Outlook

Market expansion is constrained by raw material costs and regulatory complexities but remains favorable driven by pharmaceutical and food industry growth. Innovations in eco-friendly extraction processes and bio-based derivates could influence future supply chains and costs.

Key Takeaways

• The global potassium citrate market is projected to reach USD 350 million by 2030, with 4.5% CAGR.
• The pharmaceutical sector constitutes the primary demand driver due to kidney stone management.
• The food additive segment contributes significantly, with growth tied to processed food expansion.
• Raw material costs and regulatory environments are principal market barriers.
• Investments focus on capacity expansion, process efficiency, and sustainable sourcing.

FAQs

1. What are the primary use cases of potassium citrate in pharmaceuticals?
It is used mainly for preventing kidney stones, treating metabolic acidosis, and as an electrolyte supplement.

2. How does regional regulation impact market growth?
Stringent regulations can delay product approvals, especially in emerging markets, impacting supply and demand.

3. What is the impact of raw material price fluctuations?
Raw material price volatility affects profit margins but can be mitigated through long-term supply agreements and diversified sourcing.

4. Which regions dominate potassium citrate production and consumption?
Asia-Pacific, notably China and India, leads in raw material production; North America and Europe have strong pharmaceutical markets.

5. What are potential future innovations in potassium citrate sourcing?
Bio-based extraction methods, sustainable mining practices, and environmentally friendly manufacturing processes are under development.

---

References

1. MarketsandMarkets. (2023). Potassium citrate market report.
2. Statista. (2022). Global kidney stone prevalence statistics.
3. Pharmacopoeia standards. (2021). USP, EP, and JP monographs on potassium citrate.
4. Asian Chemical Industry Reports. (2023). Regional production and application in Asia-Pacific.
5. Environmental Impact Assessments for potassium salt mines. (2022).